Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1999 · 25 citations · 10 references
MedicinePharmacologyPharmacotherapyNeurodegenerationNeuropharmacologyAntifibrotic TherapyNeurodegenerative Disease PharmacologyNeurodegenerative Disease PharmacotherapyParkinson DiseaseParkinsonian DisordersAgonist ActivityDopaminergic PathwaysDopaminergic Therapy ManagementParkinson's Disease PharmacotherapyParkinson’s Disease PharmacotherapyParkinson’s Disease TreatmentRetroperitoneal Fibrosis
Pergolide is a dopaminergic agonist used to treat Parkinson's disease but is associated with the development of retroperitoneal fibrosis (RPF). Newer nonergot agents (pramipexole, ropinirole) may not carry this same risk. A patient with a history of pergolide-induced RPF was treated successfully with ropinirole for 1 year without complications.
10
Retroperitoneal Fibrosis and Ergot Derivatives
John F. Stecker, Harvey P. Rawls, Charles J. Devine et al. · The Journal of Urology · 1974 · 52 citations
Silent retroperitoneal fibrosis associated with methysergide therapy.
Arthur H. Elkind, Arnold P. Friedman, Arnold L. Bachman et al. · PubMed · 1968 · 32 citations